KeyBanc Remains Positive on Life Sciences as 'Strong' Earning Season Begins with Danaher (DHR) Report

UBS on Danaher (DHR): 'we believe the CPHD platform will continue to see traction as COVID-19 becomes endemic'

July 21, 2022 11:24 AM EDT

UBS analyst Elizabeth Garcia reiterated a Buy rating and $297.00 price target on Danaher (NYSE: DHR).

The analyst comments "DHR kicked off 2Q22 life sciences tools earnings and reported a 2Q beat driven by the base business (+8% vs. +MSD% guidance) and COVID (+1.5% vs. -LSD... More

Cowen Reiterates Outperform Rating on Danaher (DHR), 'We expect the stock to react favorably'

July 21, 2022 10:22 AM EDT

Cowen analyst Dan Brennan reiterated an Outperform rating and $343.00 price target on Danaher (NYSE: DHR).

The analyst comments "Total organic growth of 9.5% well ahead of 'LSD%' guide and our 1.8%, with organic growth ex COVID testing ('base growth') of 8.0% ahead of our 4.3%.... More

Stifel Reiterates Hold Rating on Danaher (DHR), 'we are impressed with the company's ability to perform'

July 21, 2022 10:21 AM EDT

Stifel analyst Daniel Arias reiterated a Hold rating and {REMOVEPT} price target on Danaher (NYSE: DHR).

The analyst comments "Danaher reported 2Q22 revenues of $7.75B (+7.5% y/y), which was above Stifel ($7.12B) and consensus ($7.31B). Core revenue growth of 9.5% was ahead of expectations on... More

Thermo Fisher Scientific (TMO), Other Danaher (DHR) Peers Surge

July 21, 2022 10:18 AM EDT

Thermo Fisher Scientific (NYSE: TMO) and other Danaher (NYSE: DHR) peers surged following strong results from Danaher.

PerkinElmer (NYSE: PKI)Agilent Technologies (NYSE: A)Repligen (NASDAQ: RGEN)Pacific Bio (NASDAQ: PACB)Bio-Rad Labs (NYSE: BIO)Illumina (NASDAQ: ILMN)Waters Corp. (NYSE: WAT)Avantor (NYSE: AVTR)
... More

Danaher (DHR) Tops Q2 EPS by 40c

July 21, 2022 6:03 AM EDT

Danaher (NYSE: DHR) reported Q2 EPS of $2.76, $0.40 better than the analyst estimate of $2.36. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.32 billion.

For earnings history and earnings-related data on Danaher (DHR) click here.

... More

Stocks expected to have increasing option volume: DHR T PM BX KEY DGX

July 21, 2022 5:23 AM EDT

Stocks expected to have increasing option volume: DHR T PM BX KEY DGX

... More

UBS Starts Danaher (DHR) at Buy

July 20, 2022 5:06 AM EDT

UBS analyst Elizabeth Garcia initiates coverage on Danaher (NYSE: DHR) with a Buy rating and a price target of $297.00.

For an analyst ratings summary and ratings history on Danaher click here. For more ratings news on Danaher click here.

Shares of Danaher closed at $255.75 yesterday.

... More